UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
基本信息
- 批准号:10409646
- 负责人:
- 金额:$ 53.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAppointmentBiomedical EngineeringBlindnessCareer MobilityClinical SciencesCollaborationsCommunicationCustomEpidemiologyFacultyFundingGeneticGrantHealthHealth SciencesHumanInjuryInstitutionInvestigationLeadershipMentored Clinical Scientist Development ProgramMentorsMentorshipMethodologyMonitorNatural regenerationNerve DegenerationOphthalmologyOralOutcomeProgram EvaluationRandomized Clinical TrialsRecordsReproducibilityResearchResearch PersonnelSECTM1 geneScienceScientistStrategic PlanningStructureTalentsTherapeuticTimeTrainingTranslational ResearchVisionVisual system structureWorkWritingcareercareer developmentdidactic educationglobal healthimprovedinnovationprogramsresearch and developmentresponsible research conductskillssuccessvision science
项目摘要
PROJECT SUMMARY/ABSTRACT
We propose the establishment of a UCSF-Proctor Clinician Vision Scholars K12 program for the mentoring and
training of talented and diverse faculty Scholars in high quality, reproducible scientific research and the
development of successful academic careers in ophthalmology and vision sciences. UCSF is one of the world’s
leading health sciences institutions and this program will build on existing strengths in clinical and translational
sciences, bioengineering, and career development. The objectives of the program are to 1) mentor and train
exceptional and diverse junior faculty in developing methodological expertise and impactful research programs;
and 2) transition the K12 Scholars to become independent investigators and successful academic careers. Two
clinician-scientists with complementary scientific expertise and leadership skills will co-direct the program. An
accomplished group of Mentors with broad expertise and strong records of mentorship and collaboration will
provide the Scholars with structured mentorship across three Tracks. Track 1 is focused on
epidemiology/randomized clinical trials/global health, Track 2 on basic and translational discovery science,
specifically around the themes of ocular genetics & therapeutics, visual system injury, plasticity, & regeneration,
and neurodegeneration, and Track 3 on bioengineering and innovation investigations. Key activities in the
training plan include: 1) high-quality mentored research; 2) a customized didactic curriculum tailored to the Track;
3) career development and academic success skills; 4) detailed plan for transition to independence; and 5)
training in the responsible conduct of research. The career development and transition to independence activities
emphasize oral and written communication, grant writing, leadership, networking, responsible conduct of
research, and scientific management skills. An Advisory Committee will work with the program directors to select
K12 Scholars, monitor their progress, and identify opportunities for program quality improvement. An External
Advisory Board will also provide input on program evaluation and strategic planning. The planned duration of
appointments is three years and the projected number of junior faculty Scholars is two training at any given time.
The intended outcomes for Scholars are engagement in rigorous, reproducible research, the development of
funded independent ophthalmology and vision science research programs with a lasting impact on the field and
a focus on improving human health and alleviating blindness, and the advancement of successful academic
careers as leaders and mentors in the field.
项目摘要/摘要
我们建议建立UCSF-Proctor临床医生愿景学者K12计划的心理和
在高质量,可重复的科学研究中培训才华横溢的教师学者
在眼科和视力科学领域的成功学术职业发展。 UCSF是世界上的
领先的健康科学机构,该计划将基于临床和转化的现有优势
科学,生物工程和职业发展。该计划的目标是1)指导和培训
杰出的和潜水员的初级教师在开发方法论专业知识和有影响力的研究计划方面;
2)过渡K12学者将成为独立的研究人员和成功的学术职业。二
具有完整科学专业知识和领导能力的临床科学家将共同指导该计划。一个
具有广泛专业知识和强大的指导和协作记录的成熟导师将会
在三个曲目中为学者提供结构化的精神训练。曲目1专注于
流行病学/随机临床试验/全球健康,基本和翻译科学的轨道2,
特别是围绕眼遗传学和治疗,视觉系统损伤,可塑性和再生的主题
和神经变性,并在生物工程和创新研究中进行轨道3。关键活动
培训计划包括:1)高质量的指导研究; 2)量身定制的定制教学课程;
3)职业发展和学术成功技能; 4)过渡到独立的详细计划; 5)
负责研究的培训。职业发展和向独立活动的过渡
强调口头和书面交流,赠款写作,领导力,网络,负责任的行为
研究和科学管理技能。咨询委员会将与计划董事合作以选择
K12学者,监控他们的进度并确定计划质量改进的机会。外部
咨询委员会还将提供有关计划评估和战略计划的意见。计划的持续时间
任命为三年,预计的初级教师学者数量在任何给定时间是两次培训。
学者的预期结果是参与严格,可重复的研究,发展
资助的独立眼科和视觉科学研究计划对该领域产生持久影响
专注于改善人类健康和减轻失明,以及成功学术的进步
职业是该领域的领导者和导师。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS M LIETMAN其他文献
THOMAS M LIETMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS M LIETMAN', 18)}}的其他基金
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10439385 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10616840 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10397057 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10610924 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10907941 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10618166 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10397960 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10457913 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10222699 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10666415 - 财政年份:2019
- 资助金额:
$ 53.14万 - 项目类别:
相似国自然基金
面向一站式预约的门诊患者多检查动态调度优化研究
- 批准号:72371200
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
面向公平性的限行兼预约机制建模、分析与优化
- 批准号:72371010
- 批准年份:2023
- 资助金额:40.00 万元
- 项目类别:面上项目
面向集卡预约环境的港口集疏运道路作业计划与管控方法
- 批准号:52372303
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
考虑乘客消单行为的网约车拼车即时和预约订单联合派送优化研究
- 批准号:52302392
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
考虑医患自适应行为的医生门诊序列预约调度优化
- 批准号:72301058
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10610924 - 财政年份:2020
- 资助金额:
$ 53.14万 - 项目类别:
Administration - Resource for Molecular Imaging Agents in Precision Medicine
管理 - 精准医学中分子成像剂的资源
- 批准号:
10226207 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别:
Sources, Transport, Exposure and Effects of PFASs (STEEP)
PFAS 的来源、传输、暴露和影响 (STEEP)
- 批准号:
9258539 - 财政年份:2017
- 资助金额:
$ 53.14万 - 项目类别: